Clinical trial

LBBAP Data Collection Registry

NCT05887323

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2023-04-25

PhaseN/A

Study timeline

Study start (actual)2023-04-25Date precision: day

Registry last updated2024-10-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Bradycardiaunresolved

Sinus Node Dysfunctionunresolved

Heart Blockunresolved

Syncopeunresolved

Cardiomyopathiesunresolved

Heart Failureunresolved

Interventions

Implantation of the Tendril 2088 lead in the LBBADEVICE

Sponsors & collaborators

Abbott Medical Deviceslead sponsor

Mapped research locations

SingaporeSingapore2 PensacolaFlorida, United States1 DanvillePennsylvania, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05887323 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.